Skip to main content
PTSD & Trauma

TMS for Combat-Related PTSD: Systematic Review and Meta-Analysis

Grade DSystematic review and meta-analysis2026

What did this study find?

This review pooled seven studies with 963 participants with combat-related PTSD. Symptoms fell substantially after TMS within treated groups, but in the three trials comparing active TMS with sham, the difference was not statistically significant. The authors concluded that the specific advantage of TMS over sham remains uncertain.

What are the details of this record?

Full citation
Virto-Farfan H, Váscones-Román FF, Rivera V, et al. Efficacy of transcranial magnetic stimulation in the treatment of combat-related PTSD: a systematic review and meta-analysis. Front Psychiatry. 2026;17:1756576. doi:10.3389/fpsyt.2026.1756576.
Journal
Frontiers in Psychiatry
Authors
Virto-Farfan H, Váscones-Román FF, Rivera V, Karpenko O, Bochkina E, Parshakova E, Sinev A, Tafet GE, Pacheco-Barrios N
Study design
Systematic review and meta-analysis
Sample size and population
7 studies, 963 participants with combat-related PTSD
Evidence grade
Grade D on the BioReg grading scale
Reported findings
Within-group symptom reduction after TMS was large, but the three sham-controlled trials (116 participants) showed a non-significant pooled difference against sham (MD -3.83, 95% CI -16.32 to 8.65). The authors state a substantial portion of improvement may reflect non-specific or shared therapeutic factors.

A positive PEMF study is not evidence for a specific device unless the signal parameters studied, frequency, intensity, waveform, and exposure duration, are reasonably comparable to what that device produces. Where this record does not list those parameters, the source report did not publish them. See the grading methodology. Library last reviewed 2026-08-27.